Tech Company Financing Transactions

Boundless Bio Funding Round

Boundless Bio closed a $100 million Series C financing round on 5/16/2023. Backers included Alexandria Venture Investments, Arch Venture Partners and City Hill Ventures.

Transaction Overview

Company Name
Announced On
5/16/2023
Transaction Type
Venture Equity
Amount
$100,000,000
Round
Series C
Proceeds Purpose
The company intends to use the funds to advance BBI-355, an ecDNA-directed therapy (ecDTx), through meaningful clinical readouts from its ongoing Phase 1/2 clinical trial in patients with oncogene-amplified cancers, and a preclinical pipeline of differentiated ecDTx candidates and its proprietary ecDNA diagnostic clinical trial assay, ECHO (ecDNA Harboring Oncogenes), which is being developed in partnership with SOPHiA GENETICS.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11099 North Torrey Pines Rd. 280
La Jolla, CA 92037
USA
Email Address
Overview
Developing an entirely new class of therapeutics requires boldness, commitment, creativity, and an entrepreneurial spirit. We are building a team of pioneers committed to driving a scientific revolution in how the most difficult-to-treat cancers are understood and treated.
Profile
Boundless Bio LinkedIn Company Profile
Social Media
Boundless Bio Company Twitter Account
Company News
Boundless Bio News
Facebook
Boundless Bio on Facebook
YouTube
Boundless Bio on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Zachary Hornby
  Zachary Hornby LinkedIn Profile  Zachary Hornby Twitter Account  Zachary Hornby News  Zachary Hornby on Facebook
Chief Scientific Officer
Chris Hassig
  Chris Hassig LinkedIn Profile  Chris Hassig Twitter Account  Chris Hassig News  Chris Hassig on Facebook
Chief Technical Officer
Jason Christiansen
  Jason Christiansen LinkedIn Profile  Jason Christiansen Twitter Account  Jason Christiansen News  Jason Christiansen on Facebook
Vice President
Shailaja Kasibhatla
  Shailaja Kasibhatla LinkedIn Profile  Shailaja Kasibhatla Twitter Account  Shailaja Kasibhatla News  Shailaja Kasibhatla on Facebook
Vice President
Anthony Pinkerton
  Anthony Pinkerton LinkedIn Profile  Anthony Pinkerton Twitter Account  Anthony Pinkerton News  Anthony Pinkerton on Facebook
VP - Human Resources
Meredith Wesley
  Meredith Wesley LinkedIn Profile  Meredith Wesley Twitter Account  Meredith Wesley News  Meredith Wesley on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/16/2023: Metaphore Biotechnologies venture capital transaction
Next: 5/17/2023: Axis venture capital transaction

 

Share this article

 


About Database of VC Transactions

We report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary